Search Results - "Chel Hun Choi"

Refine Results
  1. 1

    Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy by Jihye Kim, Chel Hun Choi

    Published in Obstetrics & gynecology science (30-07-2024)
    “…Significant progress has been made in the molecular diagnosis of cancer. It provides personalized medicine, including cancer diagnosis, prognosis, targeted…”
    Get full text
    Journal Article
  2. 2

    Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer by Paik, E Sun, Kim, Tae-Hyun, Cho, Young Jae, Ryu, Jiyoon, Choi, Jung-Joo, Lee, Yoo-Young, Kim, Tae-Joong, Choi, Chel-Hun, Kim, Woo Young, Sa, Jason K., Lee, Jin-Ku, Kim, Byoung-Gie, Bae, Duk-Soo, Han, Hee Dong, Ahn, Hyung Jun, Lee, Jeong-Won

    Published in Scientific reports (17-03-2020)
    “…Axitinib, small molecule tyrosine kinase inhibitor, demonstrates anti-cancer activity for various solid tumors. We investigated anti-cancer effect of axitinib…”
    Get full text
    Journal Article
  3. 3

    Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer by Kim, Hyun-Soo, Yoon, Gun, Ryu, Ji-Yoon, Cho, Young-Jae, Choi, Jung-Joo, Lee, Yoo-Young, Kim, Tae-Joong, Choi, Chel-Hun, Song, Sang Yong, Kim, Byoung-Gie, Bae, Duk-Soo, Lee, Jeong-Won

    Published in Oncotarget (29-09-2015)
    “…Sphingosine kinase 1 (SPHK1), an oncogenic kinase, has previously been found to be upregulated in various types of human malignancy and to play a crucial role…”
    Get full text
    Journal Article
  4. 4

    Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours by Song, Taejong, Hun Choi, Chel, Lee, Yoo-Young, Kim, Tae-Joong, Lee, Jeong-Won, Bae, Duk-Soo, Kim, Byoung-Gie

    Published in Human reproduction (Oxford) (01-08-2011)
    “…BACKGROUND The aim of this study was to compare the oncologic and reproductive outcomes of patients with borderline ovarian tumours (BOTs) who were treated…”
    Get full text
    Journal Article
  5. 5

    Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma by Song, Joon Seon, Yi, Joo Mi, Cho, Hanbyoul, Choi, Chel Hun, Park, Yoonho, Chung, Eun Joo, Song, Jaewhan, Chung, Joon-Yong, Hong, Seung-Mo

    Published in Tumor biology (01-10-2018)
    “…Oncogene-induced senescence occurs following oncogene activation in normal cells and is considered as a critical tumor-suppressing mechanism…”
    Get full text
    Journal Article
  6. 6

    Single Port Access Laparoscopic Adnexal Surgery by Kim, Tae-Joong, MD, Lee, Yoo-Young, MD, Kim, Min Jae, MD, Kim, Chul Jung, MD, Kang, Heeseok, MD, Choi, Chel Hun, MD, Lee, Jeong-Won, MD, Kim, Byoung-Gie, MD, Ph.D, Bae, Duk-Soo, MD, PhD

    Published in Journal of minimally invasive gynecology (01-09-2009)
    “…Abstract Study Objective To estimate the feasibility, safety, and operative outcomes for the management of adnexal masses by single port access (SPA)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Long-term Outcomes of MRI Stage IIB Cervical Cancer by Yoon, Aera, Park, Jung Jae, Park, Byung Kwan, Lee, Yoo-Young, Paik, E Sun, Choi, Chel-Hun, Kim, Tae-Joong, Kim, Chan Kyo, Lee, Jeong-Won, Bae, Duk-Soo, Kim, Byoung-Gie

    “…Magnetic resonance imaging (MRI) can be used to assess parametrial invasion (PMI) in cervical cancer. Discordance between MRI findings and International…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum by Yoon, Gun, Kim, Hyun-Soo, Lee, Yoo-Young, Kim, Tae-Joong, Choi, Chel-Hun, Kim, Byoung-Gie, Bae, Duk-Soo, Hwang, Ji Hye, Lee, Jeong-Won

    Published in Archives of gynecology and obstetrics (01-01-2016)
    “…Objective To assess the clinical outcomes of surgical treatment for acquired vulvar lymphangioma circumscriptum in patients who received radical surgery and/or…”
    Get full text
    Journal Article
  12. 12

    Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy by Won Kyung Cho, Hyun-soo Kim, Won Park, Chi-son Chang, Yoo-young Lee, Chel Hun Choi, Tae-joong Kim, Jeong-won Lee, Byoung-gie Kim

    Published in Journal of gynecologic oncology (01-11-2022)
    “…Objective: The recently updated World Health Organization classification divides endocervical adenocarcinomas (ADCs) into human papillomavirus (HPV)-associated…”
    Get full text
    Journal Article
  13. 13

    Advantages of laparoscopy in gynecologic surgery in elderly patients by Jaewon Na, Young Eun Chung, Il-yeo Jang, Yoo-young Lee, Tae-joong Kim, Jeong-won Lee, Byoung-gie Kim, Chi-son Chang, Chel Hun Choi

    Published in Obstetrics & gynecology science (30-03-2024)
    “…Objective Geriatric patients requiring gynecological surgery is increasing worldwide. However, older patients are at higher risk of postoperative morbidity and…”
    Get full text
    Journal Article
  14. 14

    Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines by Banghyun Lee, Suk-joon Chang, Byung Su Kwon, Joo-hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin-wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-yun Lee, Dong Hoon Suh, Yong Beom Kim

    Published in Journal of gynecologic oncology (01-01-2024)
    “…Since the latest practice guidelines for ovarian cancer were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2021, many studies have examined…”
    Get full text
    Journal Article
  15. 15

    Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial by Jung-yun Lee, Byoung-gie Kim, Jae-weon Kim, Jung Bok Lee, Eunhyang Park, Je-gun Joung, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim

    Published in Journal of gynecologic oncology (01-07-2022)
    “…Objective: Management of heavily pre-treated platinum-resistant ovarian cancer remains a therapeutic challenge. Outcomes are poor with non-platinum,…”
    Get full text
    Journal Article
  16. 16

    Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features by Nalee Kim, Won Park, Won Kyung Cho, Duk-soo Bae, Byoung-gie Kim, Jeong-won Lee, Chel Hun Choi, Tae-joong Kim, Yoo-young Lee

    Published in Journal of gynecologic oncology (01-09-2021)
    “…Objective: Unlike cervical squamous cell carcinoma, there are no consensus criteria for serum tumor markers in cervical adenocarcinoma. This study aimed to…”
    Get full text
    Journal Article
  17. 17

    Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review by Kim, Myeong Seon, Choi, Chel-Hun, Kim, Tae-Joong, Lee, Jeong-Won, Lee, Jeeyun, Bae, Duk-Soo, Kim, Byoung-Gie

    Published in Obstetrics & gynecology science (01-07-2018)
    “…Malignant melanoma of the genital tract is a rare disease that is usually diagnosed by chance. When a definite diagnosis is delayed, the prognosis is very poor…”
    Get full text
    Journal Article
  18. 18

    A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01) by Yong Jae Lee, Myong Cheol Lim, Byoung-gie Kim, Natalie Yl Ngoi, Chel Hun Choi, Sang-yoon Park, David Sp Tan, Yunjung Go, Jung-yun Lee

    Published in Journal of gynecologic oncology (01-03-2021)
    “…Background: The optimal treatment of BRCA wild-type patients with platinum-sensitive recurrent ovarian cancer remains unknown. Recently, there is an increase…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy by Kim, Jihye, Choi, Chel Hun

    Published in Obstetrics & Gynecology Science (01-07-2024)
    “…Significant progress has been made in the molecular diagnosis of cancer. It provides personalized medicine, including cancer diagnosis, prognosis, targeted…”
    Get full text
    Journal Article